Postpartum Depression and Psychosis and Subsequent Severe Mental Illnesses in Mothers and Neurodevelopmental Disorders in Children: A Nationwide Study

Instructions

Click the red REGISTER button to pay the $10 fee and take the posttest
Click here to return to the JCP CME article.

Overview

Is there an association between postpartum depression or psychosis and subsequent disorders in either the mother or the child who is exposed to postpartum maternal illness?


Read the whole article at psychiatrist.com here: 
Postpartum Depression and Psychosis and Subsequent Severe Mental Illnesses in Mothers and Neurodevelopmental Disorders in Children: A Nationwide Study

© Copyright 2021 Physicians Postgraduate Press, Inc.

Target Audience

Psychiatrists

Learning Objectives

Closely monitor the mental health of women in the postpartum period

Activity summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Activity opens: 
07/27/2021
Activity expires: 
08/31/2023
Cost:
$10.00
Rating: 
0

CME Background

Articles are selected for credit designation based on an assessment of the educational needs of CME participants, with the purpose of providing readers with a curriculum of CME articles on a variety of topics throughout each volume. Activities are planned using a process that links identified needs with desired results.

CME Objective

After studying this article, you should be able to:

  • Closely monitor the mental health of women in the postpartum period

Statement of Need and Purpose

Although screening new mothers for postpartum depression is recommended by guidelines, many clinicians do not do so regularly. To improve screening and care, education for clinicians is needed about the frequency with which postpartum depression and other mental illnesses occur and may lead to subsequent disorders among the mothers and their offspring.

Release, Expiration, and Review Dates

This educational activity was published in July 2021 and is eligible for AMA PRA Category 1 Credit™ through August 31, 2023. The latest review of this material was July 2021.

Disclosure of Off-Label Usage

The authors have determined that, to the best of their knowledge, no investigational information about pharmaceutical agents or device therapies that is outside US Food and Drug Administration–approved labeling has been presented in this activity.

Funding/Support

The study was supported by grants from Taipei Veterans General Hospital (V106B-020, V107B-010, V107C-181, V108B-012, V-110C-025, V110B-002), Yen Tjing Ling Medical Foundation (CI-109-21, CI-109-22, CI-110-30), and Ministry of Science and Technology, Taiwan (107-2314-B-075-063-MY3, 108-2314-B-075-037).

Role of the Sponsor

The funding source had no role in any process of our study.

Acknowledgments

The authors thank Mr I-Fan Hu, MA (Courtauld Institute of Art, University of London; National Taiwan University) for his friendship and support. Mr Hu declares no conflicts of interest.

Faculty Affiliation

Mu-Hong Chen, MD, PhD†
Department of Psychiatry, Taipei Veterans General Hospital, Taipei, and Division of Psychiatry, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan

Tai-Long Pan, PhD†
School of Traditional Chinese Medicine, Chang Gung University, Taoyuan, and Liver Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan

Ya-Mei Bai, MD, PhD
Department of Psychiatry, Taipei Veterans General Hospital, Taipei, and Division of Psychiatry, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan

Kai-Lin Huang, MD
Department of Psychiatry, Taipei Veterans General Hospital, Taipei, and Division of Psychiatry, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan

Shih-Jen Tsai, MD
Department of Psychiatry, Taipei Veterans General Hospital, Taipei, and Division of Psychiatry, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan

Tung-Ping Su, MD
Department of Psychiatry, Taipei Veterans General Hospital, Taipei; Division of Psychiatry, School of Medicine, National Yang Ming Chiao Tung University, Taipei; and Department of Psychiatry, Cheng Hsin General Hospital, Taipei, Taiwan

Tzeng-Ji Chen, MD, PhD
Department of Family Medicine, Taipei Veterans General Hospital, Taipei, and Institute of Hospital and Health Care Administration, National Yang Ming Chiao Tung University, Taipei, Taiwan

Ju-Wei Hsu, MD*
Department of Psychiatry, Taipei Veterans General Hospital, Taipei, and Division of Psychiatry, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan

†Equally contributed

*Corresponding author: Ju-Wei Hsu, MD, Department of Psychiatry, No. 201, Shih-Pai Rd, Sec. 2, 11217, Taipei, Taiwan (jwhsu@vghtpe.gov.tw).

Financial Disclosure

All individuals in a position to influence the content of this activity were asked to complete a statement regarding all relevant personal financial relationships between themselves or their spouse/partner and any commercial interest. The CME Institute has resolved any conflicts of interest that were identified. In the past year, Marlene P. Freeman, MD, Editor in Chief of The Journal of Clinical Psychiatry, has received research funding from JayMac and Sage; has been a member of the advisory boards for Otsuka, Alkermes, and Sunovion; has been a member of the Independent Data Safety and Monitoring Committee for Janssen; has been a member of the Steering Committee for Educational Activities for Medscape; and, as a Massachusetts General Hospital (MGH) employee, works with the MGH National Pregnancy Registry, which is sponsored by Teva, Alkermes, Otsuka, Actavis, and Sunovion, and works with the MGH Clinical Trials Network and Institute, which receives research funding from multiple pharmaceutical companies and the National Institute of Mental Health. No member of the CME Institute staff reported any relevant personal financial relationships.

All authors have no financial relationships relevant to this article to disclose.

Accreditation Statement

The CME Institute of Physicians Postgraduate Press, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

The CME Institute of Physicians Postgraduate Press, Inc., designates this journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Note: The American Nurses Credentialing Center (ANCC) and the American Academy of Physician Assistants (AAPA) accept certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Price

Cost:
$10.00
Please login or register to take this activity.

Register for free on our site to participate in this and many free CME courses. There is a $10 processing fee for this activity.